Provexis (PXS.L) Stock Price
Provexis Price
Provexis (PXS.L) Stock | ISIN GB00B0923P27 | WKN A0ETZW. The current Provexis stock price is 0.01 GBP (2026). Market capitalization is 23.48 M GBP. Provexis operates in the Non-cyclical consumption sector.
Revenue has compounded at 8.6% per year over the past 19 years to 1.29 M GBP. Provexis's net margin stands at -35%, up from -67.5% several years earlier.
Provexis stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Provexis over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Provexis stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Provexis's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Provexis Price |
|---|
Provexis Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Provexis Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M GBP) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M GBP) |
| NET INCOME (M GBP) |
| NET INCOME GROWTH (%) |
| SHARES (B) |
| DOCUMENTS |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| – | – | – | – | – | – | – | – |
| – | – | – | – | – | – | – | 300 |
| 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| – | – | – | – | – | – | – | – |
| 1.85 | 1.93 | 2.01 | 2.1 | 2.21 | 2.22 | 2.22 | 2.28 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Provexis generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Provexis retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Provexis's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Provexis has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Provexis's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Provexis stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Provexis Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Provexis business model & stock analysis
Provexis SWOT Analysis
Strengths
Provexis PLC has several strengths that contribute to its competitive advantage in the market. These include:
- Strong product portfolio: Provexis PLC offers a range of innovative and high-quality products in the healthcare industry.
- Technological expertise: The company has a strong track record of developing and utilizing cutting-edge technologies to enhance its products and services.
- Established brand and reputation: Provexis PLC has built a strong brand image and reputation through its commitment to excellence and customer satisfaction.
- Strategic partnerships: The company has successfully formed strategic alliances with key stakeholders and industry leaders to expand its market reach.
Weaknesses
Despite its strengths, Provexis PLC also has some weaknesses that may hinder its growth and success. These weaknesses include:
- Limited market presence: The company's products may have limited market penetration, making it challenging to compete with larger and more established players.
- Dependency on key customers: Provexis PLC relies heavily on a few major customers, which poses a risk if these customers reduce their purchases or switch to competitors.
- Financial constraints: The company may face financial constraints in terms of funding research and development efforts or expanding its operations.
Opportunities
Provexis PLC can leverage various opportunities in the market to drive growth and profitability. These opportunities include:
- Growing healthcare industry: The increasing demand for healthcare products and services presents avenues for Provexis PLC to expand its market share.
- Emerging markets: The company can explore untapped markets and expand its global presence, particularly in emerging economies with rising disposable incomes.
- Product diversification: Provexis PLC can explore diversifying its product offerings to cater to a wider range of customer needs and preferences.
Threats
Provexis PLC faces certain threats that may pose challenges to its operations and profitability. These threats include:
- Intense competition: The healthcare industry is highly competitive, with many players offering similar products and services.
- Regulatory challenges: Compliance with regulatory standards and obtaining necessary approvals can be time-consuming and costly for Provexis PLC.
- Market volatility: Fluctuations in market conditions and economic uncertainties may impact the demand for Provexis PLC's products.
Provexis Eulerpool Fair Value
Provexis historical P/E ratio, EBIT multiple, and P/S ratio
Provexis annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Provexis shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Provexis shareholder structure
| % | Name |
|---|---|
11.23912% | |
9.56517% | |
1.61605% | |
1.51391% | |
1.18559% | |
1.08556% | |
0.52896% | |
0.52896% | |
0.52896% | |
0.43776% |
Provexis Executives and Management Board
Mr. Ian Ford
Chief Executive Officer, Executive Director, Secretary · since 2007
Dr. Niamh O'Kennedy
Chief Scientific Officer, Executive Director
Mr. C. Dawson Buck
Non-Executive Chairman of the Board
Provexis Supply Chain
Frequently asked questions about Provexis
The business model of Provexis PLC revolves around developing and commercializing scientifically supported products. Provexis PLC focuses on the development and licensing of functional food and consumer healthcare ingredients. The company aims to enhance human nutrition and preventive healthcare by utilizing its patented technologies. Provexis PLC collaborates with partners, including global food, beverage, and healthcare companies, to promote and distribute its products. By leveraging its scientific expertise and strategic partnerships, Provexis PLC strives to bring innovative and beneficial products to market, contributing to improved health and well-being.
Provexis stock
Provexis Peer Group
Provexis Ticker
Provexis FIGI
All fundamentals and in-depth analysis of Provexis
Our stock analysis for Provexis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Provexis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.